Please enable JavaScript to continue using this application.

Compare $ALEC vs $PYXS | Chartloom

Compare

$ALEC vs $PYXS

Alector Inc · Pyxis Oncology Inc

ALEC

Alector Inc

PYXS

Pyxis Oncology Inc

Compare $ALEC vs $PYXS

Comparing Alector Inc and Pyxis Oncology Inc

ALECAlector Inc

PYXSPyxis Oncology Inc

ALECAlector Inc

Market cap

$231M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.29x

Rev growth (TTM)

-82.9%

YTD performance

35.9%

52W performance

-32.5%

FCF yield

-68.6%

PYXSPyxis Oncology Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-14.2%

YTD performance

76.5%

52W performance

-30.2%

FCF yield

-40.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALEC

PYXS

Detailed metrics comparison

ALEC

Alector Inc

PYXS

Pyxis Oncology Inc

Market Cap

ALEC$231M

PYXS$168M

Enterprise Value

ALEC$181M

PYXS$150M

Price

ALEC$2.08

PYXS$2.03

P/E Ratio

ALECN/A

PYXSN/A

P/S Ratio

ALEC16.66x

PYXS15.26x

EV/Sales

ALEC13.05x

PYXS13.55x

EV/EBITDA

ALEC3.60x

PYXS0.00x

P/B Ratio

ALEC19.47x

PYXS15.60x

P/FCF Ratio

ALECN/A

PYXSN/A

EV/FCF

ALEC-1.14x

PYXS-2.20x

PEG Ratio

ALECN/A

PYXSN/A

Forward P/E (NTM)

ALECN/A

PYXSN/A

Forward P/S (NTM)

ALEC34.29x

PYXSN/A

Revenue (TTM)

ALEC$14M

PYXS$11M

Revenue Growth (YoY)

ALEC-82.9%

PYXS-14.2%

Forward Rev Growth

ALEC281.0%

PYXS14187.3%

Gross Margin (TTM)

ALEC0.0%

PYXS78.4%

Operating Margin (TTM)

ALEC0.0%

PYXS0.0%

EBITDA Margin (TTM)

ALEC-879.7%

PYXS-580.0%

Net Margin (TTM)

ALEC-850.1%

PYXS-593.0%

FCF Margin (TTM)

ALEC-1142.6%

PYXS-615.3%

Net Income (TTM)

ALEC$-118M

PYXS$-65M

FCF (TTM)

ALEC$-158M

PYXS$-68M

EPS (TTM)

ALEC-$1.06

PYXS-$1.03

ROE (TTM)

ALEC-29517.0%

PYXS-10177.0%

ROA (TTM)

ALEC-4400.0%

PYXS-6981.0%

ROIC (TTM)

ALEC-24053.0%

PYXS-10171.0%

Cash

ALEC$60M

PYXS$19M

Debt

ALEC$10M

PYXS$0

Net Cash/Debt

ALEC$50M

PYXS$19M

Current Ratio (TTM)

ALEC5.26x

PYXS1.34x

Quick Ratio (TTM)

ALEC5.05x

PYXS1.25x

Debt/Equity (TTM)

ALEC0.94x

PYXS0.00x

Debt/Assets (TTM)

ALEC0.0%

PYXS0.0%

Interest Coverage (TTM)

ALECN/A

PYXSN/A

Net Debt/EBITDA (TTM)

ALEC0.00x

PYXS0.00x

Beta

ALEC0.65

PYXS1.37

52W Performance

ALEC-32.5%

PYXS-30.2%

YTD Performance

ALEC35.9%

PYXS76.5%

% from 52W High

ALEC-38.8%

PYXS-63.4%

% from 52W Low

ALEC90.8%

PYXS97.1%

Asset Turnover (TTM)

ALEC0.05x

PYXS0.00x

FCF Yield (TTM)

ALEC-68.6%

PYXS-40.3%

Earnings Yield (TTM)

ALEC-51.0%

PYXS-38.9%

Dividend Yield (TTM)

ALECN/A

PYXSN/A

Rule of 40

ALEC-1,225.5

PYXS-629.5

EV/GP/RG

ALECN/A

PYXS0.00

Ticker research

View ALEC research View PYXS research

Metric	ALEC Alector Inc	PYXS Pyxis Oncology Inc
Market & Valuation
Market Cap	$231M	$168M
Enterprise Value	$181M	$150M
Price	$2.08	$2.03
P/E Ratio	N/A	N/A
P/S Ratio	16.66x	15.26x
EV/Sales	13.05x	13.55x
EV/EBITDA	3.60x	0.00x
P/B Ratio	19.47x	15.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.14x	-2.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	N/A
Revenue & Growth
Revenue (TTM)	$14M	$11M
Revenue Growth (YoY)	-82.9%	-14.2%
Forward Rev Growth	281.0%	14187.3%
Profitability
Gross Margin (TTM)	0.0%	78.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-879.7%	-580.0%
Net Margin (TTM)	-850.1%	-593.0%
FCF Margin (TTM)	-1142.6%	-615.3%
Net Income (TTM)	$-118M	$-65M
FCF (TTM)	$-158M	$-68M
EPS (TTM)	-$1.06	-$1.03
ROE (TTM)	-29517.0%	-10177.0%
ROA (TTM)	-4400.0%	-6981.0%
ROIC (TTM)	-24053.0%	-10171.0%
Financial Health
Cash	$60M	$19M
Debt	$10M	$0
Net Cash/Debt	$50M	$19M
Current Ratio (TTM)	5.26x	1.34x
Quick Ratio (TTM)	5.05x	1.25x
Debt/Equity (TTM)	0.94x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	1.37
52W Performance	-32.5%	-30.2%
YTD Performance	35.9%	76.5%
% from 52W High	-38.8%	-63.4%
% from 52W Low	90.8%	97.1%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-68.6%	-40.3%
Earnings Yield (TTM)	-51.0%	-38.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	-629.5
EV/GP/RG	N/A	0.00
Ticker research	View ALEC research	View PYXS research

Valuation

P/S Ratio

PYXS

15.26x

ALEC

16.66x

EV/FCF

PYXS

-2.20x

ALEC

-1.14x

Growth & revenue

Revenue Growth TTM

PYXS

-14.2%

ALEC

-82.9%

Forward Revenue Growth

PYXS

14187.3%

ALEC

281.0%

Profitability & performance

Gross Margin

PYXS

78.4%

ALEC

0.0%

ROE

PYXS

-10177.0%

ALEC

-29517.0%

FCF Yield %

PYXS

-40.3%

ALEC

-68.6%

52-Week Performance

PYXS

-30.2%

ALEC

-32.5%

Detailed metrics comparison

ALEC

Alector Inc

PYXS

Pyxis Oncology Inc

Market Cap

ALEC$231M

PYXS$168M

Enterprise Value

ALEC$181M

PYXS$150M

Price

ALEC$2.08

PYXS$2.03

P/E Ratio

ALECN/A

PYXSN/A

P/S Ratio

ALEC16.66x

PYXS15.26x

EV/Sales

ALEC13.05x

PYXS13.55x

EV/EBITDA

ALEC3.60x

PYXS0.00x

P/B Ratio

ALEC19.47x

PYXS15.60x

P/FCF Ratio

ALECN/A

PYXSN/A

EV/FCF

ALEC-1.14x

PYXS-2.20x

PEG Ratio

ALECN/A

PYXSN/A

Forward P/E (NTM)

ALECN/A

PYXSN/A

Forward P/S (NTM)

ALEC34.29x

PYXSN/A

Revenue (TTM)

ALEC$14M

PYXS$11M

Revenue Growth (YoY)

ALEC-82.9%

PYXS-14.2%

Forward Rev Growth

ALEC281.0%

PYXS14187.3%

Gross Margin (TTM)

ALEC0.0%

PYXS78.4%

Operating Margin (TTM)

ALEC0.0%

PYXS0.0%

EBITDA Margin (TTM)

ALEC-879.7%

PYXS-580.0%

Net Margin (TTM)

ALEC-850.1%

PYXS-593.0%

FCF Margin (TTM)

ALEC-1142.6%

PYXS-615.3%

Net Income (TTM)

ALEC$-118M

PYXS$-65M

FCF (TTM)

ALEC$-158M

PYXS$-68M

EPS (TTM)

ALEC-$1.06

PYXS-$1.03

ROE (TTM)

ALEC-29517.0%

PYXS-10177.0%

ROA (TTM)

ALEC-4400.0%

PYXS-6981.0%

ROIC (TTM)

ALEC-24053.0%

PYXS-10171.0%

Cash

ALEC$60M

PYXS$19M

Debt

ALEC$10M

PYXS$0

Net Cash/Debt

ALEC$50M

PYXS$19M

Current Ratio (TTM)

ALEC5.26x

PYXS1.34x

Quick Ratio (TTM)

ALEC5.05x

PYXS1.25x

Debt/Equity (TTM)

ALEC0.94x

PYXS0.00x

Debt/Assets (TTM)

ALEC0.0%

PYXS0.0%

Interest Coverage (TTM)

ALECN/A

PYXSN/A

Net Debt/EBITDA (TTM)

ALEC0.00x

PYXS0.00x

Beta

ALEC0.65

PYXS1.37

52W Performance

ALEC-32.5%

PYXS-30.2%

YTD Performance

ALEC35.9%

PYXS76.5%

% from 52W High

ALEC-38.8%

PYXS-63.4%

% from 52W Low

ALEC90.8%

PYXS97.1%

Asset Turnover (TTM)

ALEC0.05x

PYXS0.00x

FCF Yield (TTM)

ALEC-68.6%

PYXS-40.3%

Earnings Yield (TTM)

ALEC-51.0%

PYXS-38.9%

Dividend Yield (TTM)

ALECN/A

PYXSN/A

Rule of 40

ALEC-1,225.5

PYXS-629.5

EV/GP/RG

ALECN/A

PYXS0.00

Ticker research

View ALEC research View PYXS research

Metric	ALEC Alector Inc	PYXS Pyxis Oncology Inc
Market & Valuation
Market Cap	$231M	$168M
Enterprise Value	$181M	$150M
Price	$2.08	$2.03
P/E Ratio	N/A	N/A
P/S Ratio	16.66x	15.26x
EV/Sales	13.05x	13.55x
EV/EBITDA	3.60x	0.00x
P/B Ratio	19.47x	15.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.14x	-2.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	N/A
Revenue & Growth
Revenue (TTM)	$14M	$11M
Revenue Growth (YoY)	-82.9%	-14.2%
Forward Rev Growth	281.0%	14187.3%
Profitability
Gross Margin (TTM)	0.0%	78.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-879.7%	-580.0%
Net Margin (TTM)	-850.1%	-593.0%
FCF Margin (TTM)	-1142.6%	-615.3%
Net Income (TTM)	$-118M	$-65M
FCF (TTM)	$-158M	$-68M
EPS (TTM)	-$1.06	-$1.03
ROE (TTM)	-29517.0%	-10177.0%
ROA (TTM)	-4400.0%	-6981.0%
ROIC (TTM)	-24053.0%	-10171.0%
Financial Health
Cash	$60M	$19M
Debt	$10M	$0
Net Cash/Debt	$50M	$19M
Current Ratio (TTM)	5.26x	1.34x
Quick Ratio (TTM)	5.05x	1.25x
Debt/Equity (TTM)	0.94x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	1.37
52W Performance	-32.5%	-30.2%
YTD Performance	35.9%	76.5%
% from 52W High	-38.8%	-63.4%
% from 52W Low	90.8%	97.1%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-68.6%	-40.3%
Earnings Yield (TTM)	-51.0%	-38.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	-629.5
EV/GP/RG	N/A	0.00
Ticker research	View ALEC research	View PYXS research